ArticleCancer chemotherapy and pharmacology2026
Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib.
Agata Sałek-Zań et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.